| NCT05983250 | LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF | RECRUITING | PHASE3 | 2024-01-10 | 2028-10 | 2026-10 |
| NCT03624010 | Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients | COMPLETED | PHASE2 | 2018-11-14 | 2024-02-01 | 2024-02-01 |
| NCT03541603 | Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF | COMPLETED | PHASE2 | 2018-11-14 | 2020-04-07 | 2020-04-07 |
| NCT02025621 | Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass | COMPLETED | PHASE3 | 2014-07 | 2016-11 | 2016-11 |
| NCT00908063 | Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI) | TERMINATED | PHASE2 | 2009-10 | 2014-09 | 2014-09 |
| NCT00174980 | Study of Oxycyte in Severe Closed Head Injury | COMPLETED | PHASE2 | 2005-09 | 2008-07 | 2008-01 |